A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2009
11/26/2009	US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009	US20090291995 bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; enhanced solubility and bioavailability compared with free acid; agonist of TPO receptor, enhances platelet production; thrombocytopenia
11/26/2009	US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009	US20090291963 Substituted indoles
11/26/2009	US20090291960 Pyrrolinidium derivatives as m3 muscarinic receptors
11/26/2009	US20090291953 Pharmaceutical salts of reboxetine
11/26/2009	US20090291914 Hyaluronic acid oligosaccharide fractions and drugs containing the same
11/26/2009	US20090291889 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
11/26/2009	US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009	US20090291885 Conjugated toxin peptide therapeutic agents
11/26/2009	US20090291121 Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
11/26/2009	US20090291120 Hydrophilic Polyurethane Compositions
11/26/2009	US20090291100 Therapeutic agent for polycystic ovary syndrome (pcos)
11/26/2009	US20090291064 Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines
11/26/2009	CA2724592A1 Agent for maintenance of induced remission
11/26/2009	CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009	EP2123751A1 Novel peptide
11/25/2009	EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009	EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009	EP2123664A1 Novel sugar-linked chlorin derivative and process for production thereof
11/25/2009	EP2123662A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
11/25/2009	EP2123655A1 Bis(tetrahydrofuran) compound, method for production of the compound, and use of the compound
11/25/2009	EP2123654A1 Pyrazolopyrimidine compound
11/25/2009	EP2123651A1 Condensed pyridine compound
11/25/2009	EP2123644A1 Benzoxazepine derivatives and use thereof
11/25/2009	EP2123637A1 Novel curcumin derivative
11/25/2009	EP2123636A1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
11/25/2009	EP2123630A1 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
11/25/2009	EP2123303A1 Ameliorating agent for insulin resistance
11/25/2009	EP2123301A1 Therapeutic agent for urinary tract disease
11/25/2009	EP2123297A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
11/25/2009	EP2123287A1 Agent for preventing bleeding from cerebral cortical vein
11/25/2009	EP2123280A1 Agent for prevention and/or treatment of systemic lupus erythematosus
11/25/2009	EP2123276A1 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
11/25/2009	EP2123273A1 Therapeutic agent for urinary excretion disorder
11/25/2009	EP2123272A1 Adam inhibitor
11/25/2009	EP2123270A1 Iron metabolism-improving agent
11/25/2009	EP2123266A1 Cancer therapeutic agent and anti-carcinogenic agent
11/25/2009	EP2123255A1 Pharmaceutical composition containing fine particle oil-based suspension
11/25/2009	EP2123253A1 Wrinkling-preventing and -modifying agent
11/25/2009	EP2121586A2 Regulation of osteopontin
11/25/2009	EP2121034A1 Use of sirt7 for treating age-related diseases
11/25/2009	EP2121005A1 Treatment of fabry disease
11/25/2009	EP2120976A1 Methods for the treatment of anal incontinence
11/25/2009	EP2120963A2 Substituted tetracycline compounds for treatment of inflammatory skin disorders
11/25/2009	EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009	EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009	EP1019490B1 Methods for modulating hematopoiesis and vascular growth
11/25/2009	EP1017275B1 Polyamine treatment of neurological disorders
11/25/2009	EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009	EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585792A Preparation method of a piglet intestinal canal barrier function controlling substance -N-acetylcysteine
11/25/2009	CN101584862A Diagnosing tumorigenicity and determining resistance to anticancer therapy
11/25/2009	CN101584820A Infantile adiaphoretic Chinese medicament
11/25/2009	CN101584816A Traditional Chinese medicine for treating hernia for children
11/25/2009	CN101584741A Radix sophorae tonkinensis total flavonoids, flavone salt and preparation method thereof
11/25/2009	CN101584691A Compounds effecting glucokinase
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/25/2009	CN100562273C Medicinal ear pillow
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622485 administering plant alkaloids such as 1-deoxy-galactonojirimycin and related compounds for prophylaxis of Fabry's disease
11/24/2009	US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009	US7622479 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
11/24/2009	US7622476 1-allyl-( 5R,8S,10R)-terguride; antagonistic properties to 5-HT2 receptors for the prevention of migraine-related headache, Parkinson's disease, disorders of the thrombocyte function
11/24/2009	US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009	US7622471 Pyrazole derivatives having a pyridazine and pyridine functionality
11/24/2009	US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622450 Flavone C-glycoside derivatives and compositions containing the derivatives
11/24/2009	US7622441 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2448030C Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
11/24/2009	CA2443774C Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
11/24/2009	CA2434381C Naphthostyrils
11/24/2009	CA2433197C Gyrase inhibitors and uses thereof
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2415383C New amidino derivatives and their use as thrombin inhibitors
11/24/2009	CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/24/2009	CA2374513C Il-1 eta dna and polypeptides
11/24/2009	CA2338342C Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
11/24/2009	CA2279427C Use of low dose photodynamic therapy for reducing the effects of inflammation
11/24/2009	CA2265912C Human bad polypeptides, encoding nucleic acids and methods of use
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/24/2009	CA2200693C Gp 130 lacking the transmembrane domain
11/19/2009	WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof

1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 1564